Abstract
In this paper we describe the preparation, characterization and antimalarial activity in vivo of novel quinoline/mercatopurine conjugates. The compounds were tested in vivo in a murine model using chloroquine as a reference compound. The values of inhibition of parasite multiplication relative to chloroquine were determined and the compound 4-(6’-mercatopurine)-7-chloroquinoline was considered statistically identical to chloroquine at the same dosage. The compounds were not cytotoxic at the maximum concentration used (100 μg/mL). Possible mechanisms of action are discussed. In light of these data, the title compounds may serve as prototypes for the development of novel antimalarial agents.
Keywords: Synthesis, Antimalarial activity, Plasmodium berghei, Quinoline, Chloroquine, Mercaptopurine, Anopheles mosquitoes, P. Falciparum, Plasmodium strains, de novo drug design, chemical modification, Thiopurines, immunosupressors, 6-mercaptopurine derivates, HRMS ESI
Letters in Drug Design & Discovery
Title:Synthesis and In Vivo Antimalarial Activity of Quinoline/Mercaptopurine Conjugates
Volume: 9 Issue: 4
Author(s): Nicolli Bellotti de Souza, Rafael Carvalhaes, Arturene Maria Lino do Carmo, Marcio Jose Martins Alves and Elaine Soares Coimbra, Sonia Maria Neumann Cupolilo, Clarice Abramo, Adilson David Da Silva
Affiliation:
Keywords: Synthesis, Antimalarial activity, Plasmodium berghei, Quinoline, Chloroquine, Mercaptopurine, Anopheles mosquitoes, P. Falciparum, Plasmodium strains, de novo drug design, chemical modification, Thiopurines, immunosupressors, 6-mercaptopurine derivates, HRMS ESI
Abstract: In this paper we describe the preparation, characterization and antimalarial activity in vivo of novel quinoline/mercatopurine conjugates. The compounds were tested in vivo in a murine model using chloroquine as a reference compound. The values of inhibition of parasite multiplication relative to chloroquine were determined and the compound 4-(6’-mercatopurine)-7-chloroquinoline was considered statistically identical to chloroquine at the same dosage. The compounds were not cytotoxic at the maximum concentration used (100 μg/mL). Possible mechanisms of action are discussed. In light of these data, the title compounds may serve as prototypes for the development of novel antimalarial agents.
Export Options
About this article
Cite this article as:
Nicolli Bellotti de Souza, Rafael Carvalhaes, Arturene Maria Lino do Carmo, Marcio Jose Martins Alves and Elaine Soares Coimbra, Sonia Maria Neumann Cupolilo, Clarice Abramo, Adilson David Da Silva , Synthesis and In Vivo Antimalarial Activity of Quinoline/Mercaptopurine Conjugates, Letters in Drug Design & Discovery 2012; 9 (4) . https://dx.doi.org/10.2174/157018012799859990
DOI https://dx.doi.org/10.2174/157018012799859990 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Candida parapsilosis Secreted Lipase as an Important Virulence Factor
Current Protein & Peptide Science Telomere Recombination and the ALT Pathway: A Therapeutic Perspective for Cancer
Current Pharmaceutical Design Therapeutic Perspectives for cN-II in Cancer.
Current Medicinal Chemistry Merlin, a “Magic” Linker Between the Extracellular Cues and Intracellular Signaling Pathways that Regulate Cell Motility, Proliferation, and Survival
Current Protein & Peptide Science Treatment of Pancreatic Cancer with Pharmacological Ascorbate
Current Pharmaceutical Biotechnology Mobile Phone Text Message Interventions in Psychiatry - What are the Possibilities?
Current Psychiatry Reviews Editorial [Hot Topic:Molecular Mechanisms of and Clinical Evidence for Interactions Between Natural Products and Drugs (Guest Editor: Thomas Efferth)]
Current Drug Metabolism Selenium Deficiency in Soils and Crops and its Impact on Animal and Human Health
Current Nutrition & Food Science Editorial (Thematic Issue: Vitamin D Supplementation: Its Relevance to Obesity, Atopic Dermatitis and Depression)
Current Nutrition & Food Science Sympathetic Signaling in Angiogenesis: Implications for Cancer Progression
Current Cancer Therapy Reviews Medication-Induced Nephrotoxicity in Older Patients
Current Drug Metabolism Diamidine Activity Against Trypanosomes: The State of the Art
Current Molecular Pharmacology Epigenetics in Clinical Management of Children and Adolescents with Brain Tumors
Current Cancer Drug Targets Therapy Stratifications and Novel Approach in Pursuit of Aids Related Kaposi’s Sarcoma Management- A paradigm for Non Invasiveness
Current Drug Delivery Molecular Targets in Gastrointestinal Stromal Tumors (GIST) Therapy
Current Cancer Drug Targets An Integrative Systems Analysis of High-grade Glioma Cell Lines: TLRs, Wnt, BRCA1, Netrins, STXBP1 and MDH1 Provide Putative Molecular Targets for Therapeutic Intervention
Current Pharmacogenomics and Personalized Medicine Obesity in the Childhood: A Link to Adult Hypertension
Current Pharmaceutical Design The Neutrophil: An Underappreciated But Key Player in SLE Pathogenesis
Current Immunology Reviews (Discontinued) Immunotherapeutic and Immunoregulatory Drugs in Haematologic Malignancies
Current Topics in Medicinal Chemistry Extracellular Matrix Scaffolds for Tissue Engineering and Regenerative Medicine
Current Stem Cell Research & Therapy